The bottle is still on the counter and yesterday's tablet is still in it. Your dog is on fluoxetine for separation anxiety, or for something like it, and you have no idea whether one missed day undoes weeks of slow progress.
The first screen of search results is calm, unanimous and copied from one source: give it when you remember, skip it if the next one is close, never double up. That advice is reasonable. What none of those pages mention is that the drug in the tablet has a half-life of about six hours in a dog — so it was gone long before today's dose was due — and why that does not matter.
Key takeaways
- The drug you handed over is not the drug that is working. The label gives fluoxetine a mean half-life of 6.2 hours and norfluoxetine 49 hours, and calls the metabolite "an equipotent SSRI that contributes to the efficacy" of the product.¹
- The label's missed-dose instruction is stricter than the advice everywhere else. "If a dose is missed, the next scheduled dose should be administered as prescribed. Do not increase or double the dose."¹
- Withdrawal is not the risk here, and the label says so plainly. "To discontinue therapy, it is not necessary to taper or reduce doses because of the long half-life of this product."¹
- What a gap really costs you is the 8-week review. Improvement is assessed at 8 weeks — 73% versus 51% on training alone — and the label sets no blood test that could say whether the tablets went in.¹
I forgot my dog's fluoxetine — what should I do right now?
Follow the instruction your own vet gave you, and do not give two tablets. If you were not given one, the label that governs this drug in dogs is unusually specific: "If a dose is missed, the next scheduled dose should be administered as prescribed. Do not increase or double the dose."¹
That differs from the advice you will find on almost every other page, which comes from VCA's client handout: "if you miss a dose, give it as soon as you remember, and then continue with the regular dosing schedule. However, if it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not give the pet two doses at once."² Both are defensible and the pharmacology below explains why the difference matters far less here than it would with insulin. Your vet's instruction wins over both.
Then do the part no search result mentions: write down which dose was missed and when you noticed. Not because it changes today, but because in six weeks somebody is going to ask how consistently the drug has been given, and a guess is worth very little.
| What happened | What it means | What to do |
|---|---|---|
| A few hours late | Well inside the metabolite's working range — its mean half-life is 49 hours¹ | Either giving it now or waiting for tomorrow's is defensible here — the label and VCA differ.¹² Follow your vet, and note the real time |
| Remembered close to the next dose | Two doses within a few hours stack a peak without filling any deficit¹ | Skip it and give the next one on time. Both sources agree here. Never double¹² |
| One whole day missed | A dip in a reservoir built over months, not an interruption of treatment¹ | Resume normally. Log it so the next review knows about it |
| A week or more missed | Now a treatment gap. It is still not a withdrawal emergency, but it changes what the 8-week assessment is measuring¹ | Call the clinic before restarting, and say how many doses were missed rather than "a few" |
| New or worsening seizure activity, at any point | The label contraindicates this drug in dogs with epilepsy and records seizures in dogs without a history¹ | Contact your vet or an emergency clinic now, whether or not a dose was missed |
| Two doses went in, or your dog reached the bottle | A different problem with a different urgency — see below⁵ | Call your vet or ASPCA Animal Poison Control on (888) 426-4435⁶ |
Built from the Reconcile FDA label, VCA and the ASPCA Animal Poison Control Center. No row here is a dosing instruction — they differ in how soon you pick up the phone.
How long does fluoxetine actually stay in a dog?
Hours, if you mean the drug in the tablet. Days, if you mean the drug that is treating your dog. Those are two different molecules, and the difference is the whole answer.
The FDA-approved label for Reconcile — the fluoxetine product licensed for dogs — publishes both. After a single dose of roughly 2 mg/kg, fluoxetine reached peak plasma concentration at 1.8 hours and had a mean elimination half-life of 6.2 hours, with an individual range of 3.0 to 12.9 hours. Norfluoxetine peaked at 12.8 hours and had a mean half-life of 49 hours, ranging from 33.0 to 64.0.¹
Set the first of those against once-daily dosing and the arithmetic looks alarming. Nearly four half-lives fit inside a single day, so the drug you administered on Monday is essentially undetectable by Tuesday morning — on every ordinary day, not just the day you forgot.
The label explains why that is beside the point. Fluoxetine "is largely metabolized in the liver by cytochrome P-450 enzyme system to norfluoxetine, an equipotent SSRI that contributes to the efficacy of RECONCILE chewable tablets."¹ Equipotent is the operative word. The metabolite is not a breakdown product on its way out; it is a second active drug with eight times the exposure — the label's area-under-the-curve figures are 11.44 for norfluoxetine against 1.388 for fluoxetine.¹
So when you skip a dose, you remove a molecule that was already gone, from a system running mostly on something else.
A second finding in the same section makes this drug genuinely unlike the others in the cabinet. Steady state "appeared to be reached within 10 days" in a 21-day study — but across a one-year safety study, dogs on 1 mg/kg "had plasma fluoxetine concentrations that continued to increase over the one-year dosing period," with a similar rise in norfluoxetine.¹
A year of dosing, and the level was still climbing. In 2020, Odore and colleagues found the same shape independently in Animals, measuring "increasing concentrations of circulating fluoxetine and norfluoxetine" across six months in eight dogs.³ What your dog has on board today was built by months of tablets. One of them is not a large share of it.
Can you give two doses of fluoxetine to catch up?
No, and the label removes the usual ambiguity: "If a dose is missed, the next scheduled dose should be administered as prescribed. Do not increase or double the dose."¹ It says the same thing twice in two different sections, which for a drug label is emphasis.
The honest reason is not that a doubled dose is likely to poison your dog. It probably is not. Reviewing SSRI exposures in animals for Topics in Companion Animal Medicine in 2013, Fitzgerald and Bronstein report that "the prognosis in animals that receive treatment is excellent," and that in one retrospective study "there were no deaths in 313 SSRI-poisoned dogs."⁵
The reason to refuse is that there is nothing to catch up. Exposure here is a months-long accumulation, not a daily top-up, so the second tablet fills no deficit — it just adds a peak on a day the schedule did not plan for. That is the same logic behind never doubling up to catch up on any medication, with a clearer paper trail than most drugs offer.
What genuinely does warrant a phone call is a larger accidental ingestion — the label describes "a chewable, flavored tablet" supplied in bottles of 30 or 90.¹ Higher doses of an SSRI can produce what Fitzgerald and Bronstein describe as serotonin syndrome, manifesting "as ataxia, tremors, muscle rigidity, hyperthermia, diarrhea, and seizures."⁵ Call your vet. The ASPCA Animal Poison Control Center is on (888) 426-4435, "24/7, 365 days a year"; a consultation fee may apply.⁶
One interaction is worth naming, because a dog on fluoxetine is often on something else for the same problem. Trazodone is the usual companion, and combining serotonergic drugs is exactly when serotonin syndrome becomes possible — the point we cover in our guide to a doubled trazodone dose. If both are in the house, say so on the phone.
Will my dog go into withdrawal if doses are missed?
Almost certainly not, and here the internet's consensus and the drug's own label point in opposite directions. Search "stopping fluoxetine in dogs" and you will be told that dogs withdraw, that the taper needs three to five weeks, and that stopping abruptly brings anxiety, panting and restlessness.
The Reconcile label says this instead: "To discontinue therapy, it is not necessary to taper or reduce doses because of the long half-life of this product."¹
Read that alongside the half-lives and it stops being surprising. A drug whose active metabolite has a mean half-life of 49 hours tapers itself: stop dead on a Monday and the norfluoxetine level is still falling well over a week later. There is no cliff for a missed dose to push your dog off.
The label puts a number on how long the drug lingers, from a different angle. Because "fluoxetine and its major metabolite, norfluoxetine, have long half-lives, a 6-week washout interval should be observed following discontinuation of therapy with RECONCILE chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine."¹ Six weeks after the last tablet, this drug is still considered present enough to matter. That is the single most useful thing to know about a missed week.
Two caveats. That advice concerns the licensed 8-week course for separation anxiety, and many dogs take fluoxetine off-label and long-term for other problems — Merck lists phobias, compulsive disorders and urine marking among them.⁴ And calm about stopping is not calm about the drug: the label contraindicates it in dogs with epilepsy or a seizure history, and states that "seizures may occur in dogs treated with RECONCILE chewable tablets, even in dogs without a history of epilepsy or seizures."¹ Stopping and restarting on your own is not a small decision, even though one missed tablet is.
What does a missed dose actually cost your dog?
Not much on the day, and quite a lot at the appointment eight weeks out. This is the part the search results miss entirely, and it is the only part worth worrying about.
Fluoxetine is judged slowly. The label's client leaflet tells owners that "some dogs may show improvement within 1-2 weeks of starting treatment," while "others may take as long as 8 weeks to show improvement," and the professional section is firmer: "if no improvement is noted within 8 weeks, case management should be reevaluated."¹ That is a real decision point at which the drug may be changed, escalated or stopped.
The pivotal field study is what that verdict rests on. Across 229 dogs at 34 sites, all of them also on a behavior modification plan, 73% of dogs given the drug showed significant improvement at 8 weeks against 51% given behavior modification alone. Within the first week the split was 42% against 18%.¹ Independent work puts the underlying mood on the same clock: dogs with separation-related problems tested much like unaffected controls at weeks 2 and 6, "with this effect more pronounced at week 6."⁸
Now put a fortnight of missed doses inside that window. The 8-week review is measuring how the dog responded to the drug, but what it actually captures is how the dog responded to the doses that were given. Those are the same thing only when the schedule was kept. A drug that would have worked can be abandoned as a failure, and a dose can be raised on a dog who was simply never getting it.
The uncomfortable part is that nothing in the dog will settle the question afterwards. The label sets no blood test: it says the patient's "response to therapy should be monitored," and that "professional judgment should be used in monitoring the patient's response."¹ Where a dog on phenobarbital has a serum level, and a dog on levothyroxine has a post-dose thyroid test that a missed tablet quietly distorts, a dog on fluoxetine has only the behavior your household reports and the record of what was given. If the record is a guess, the review is a guess.
What should you watch for over the next few days?
Two things, and both are worth watching rather than worrying about. The label records weight loss of 5% or more in 29.6% of treated dogs against 13.0% of controls,¹ so appetite is worth tracking anyway. And Merck's adverse-effect list for fluoxetine runs from "anorexia, hyporexia, lethargy, sedation" through "agitation, tremors, seizures," noting that "aggression has also been reported."⁴ A change after a missed dose is worth a call, though it is at least as likely to be the anxiety itself.
| What you notice | What the sources say about it | How fast to act |
|---|---|---|
| The anxiety behaviour comes back for a day | Expected variation. Improvement in the field study was measured across weeks, not days, and 27% of treated dogs had not shown significant improvement even at week 8¹ | Log it. Raise it at the next appointment |
| Eating less, or losing weight | The commonest real effect: 29.6% of treated dogs lost 5% or more of body weight against 13.0% of controls¹ | Weigh weekly. Call if the trend continues |
| Restlessness, vocalizing, agitation | On Merck's adverse-effect list for the drug — and also, confusingly, on the list of signs it treats⁴ | Worth a call, not a conclusion |
| New aggression | Merck records that "aggression has also been reported"; the label does not recommend the drug for treating aggression at all¹⁴ | Same day. Keep people and other pets clear meanwhile |
| Tremors, unsteadiness, high temperature together | The serotonin-syndrome cluster: "ataxia, tremors, muscle rigidity, hyperthermia, diarrhea, and seizures"⁵ | Emergency care. Say what else the dog takes |
| A seizure | The label's most serious reported reaction, occurring in dogs with no seizure history¹ | Emergency care, missed dose or not |
From the Reconcile FDA label, the Merck Veterinary Manual and Fitzgerald & Bronstein (2013). These rows say what to report and how urgently, not what to treat.
Why is fluoxetine such an easy dose to lose?
Because every cue that normally protects a daily tablet is missing from this one. There is no immediate effect to notice — the label states outright that the drug "does not act as a sedative"¹ — so nothing about your dog on Tuesday tells you whether Monday's tablet went in. Fluoxetine is one of the few drugs whose entire point is invisible on the day.
It is also given for a problem that comes and goes on its own. A quiet week reads as the drug working, and a bad afternoon reads as it failing, and neither is evidence about adherence. Compare that with insulin, where a missed dose announces itself within hours.
Then there is the shape of the household. Fluoxetine is prescribed for separation anxiety, which by definition afflicts dogs who spend time alone — often in homes where two people share the mornings, and each can reasonably believe the other handled it. That ambiguity, rather than forgetfulness, is the failure we describe in our piece on why pets miss medication doses. A second alarm on a second phone does not help, because it asks a question neither person can answer.
It may also be a drug given with unusually little context around it. In 2025, reporting in the Journal of the American Veterinary Medical Association on 32,468,046 canine records from US primary-care hospitals, Weng and colleagues found fluoxetine prescribed in 0.02% of cases, and that "about 70% of dogs receiving psychoactive drugs had no associated behavior problem labels."⁷ Many of these prescriptions carry none of the documentation that would make a missed dose easy to interpret later.
Veterinary medical disclaimer: SteadyTails is a logging and coordination tool, not a substitute for veterinary care. Nothing here is a dosing instruction. Fluoxetine is a prescription drug, and the FDA-approved product for dogs is contraindicated in dogs with epilepsy or a history of seizures, alongside drugs that lower the seizure threshold, and with monoamine oxidase inhibitors; it is labeled for dogs 6 months of age or older and 8.8 pounds or more.¹ Many dogs take it off-label for problems other than separation anxiety, where the label's guidance may not apply in full. What to do about a missed dose depends on your dog, their diagnosis and their other medications, so follow the instruction your own veterinarian gave you. Never give a double or extra dose to catch up, never change a dose yourself, and never stop or restart treatment on your own. If an extra dose has been given or your dog has reached the bottle, call your vet; the ASPCA Animal Poison Control Center is on (888) 426-4435, 24/7, 365 days a year, and a consultation fee may apply.⁶ A seizure warrants emergency care regardless of whether a dose was missed.
The drug with nothing to show for itself
Fluoxetine has no blood test in general practice, no same-day effect to notice, and a verdict taken eight weeks after you started. The only evidence of whether it was given is the record somebody made at the time. SteadyTails puts every dose on one shared timeline with a timestamp and the name of whoever gave it, clears the reminder on everyone else's phone the moment it's logged, and keeps the late and missed ones instead of hiding them — so the answer at the eight-week review is a record, not a reconstruction. Coming soon to iOS and Android.
Join the SteadyTails waitlist →References
- Pegasus Laboratories, Inc. RECONCILE (fluoxetine hydrochloride) chewable tablets — FDA-approved animal drug label, NADA 141-272, via DailyMed. Dosage: "the recommended dose of RECONCILE chewable tablets is 1-2 mg/kg (0.5-0.9 mg/lb) administered once daily, in conjunction with a behavior modification plan." Missed dose: "if a dose is missed, the next scheduled dose should be administered as prescribed. Do not increase or double the dose." Discontinuation: "to discontinue therapy, it is not necessary to taper or reduce doses because of the long half-life of this product." Reassessment and monitoring: "the patient's response to therapy should be monitored. If no improvement is noted within 8 weeks, case management should be reevaluated"; "professional judgment should be used in monitoring the patient's response to therapy to determine the need to continue treatment with RECONCILE chewable tablets beyond 8 weeks"; the label sets no serum monitoring requirement. Description: "RECONCILE is a chewable, flavored tablet that contains fluoxetine hydrochloride." Clinical pharmacology: fluoxetine "is largely metabolized in the liver by cytochrome P-450 enzyme system to norfluoxetine, an equipotent SSRI that contributes to the efficacy of RECONCILE chewable tablets"; "fluoxetine does not act as a sedative"; Table 4, single dose at approximately 2 mg/kg — fluoxetine AUC 1.388 (±0.137) µg·hr/mL, Cmax 126.6 (±12.3) ng/mL, Tmax 1.8 (±0.2) h, T½ 6.2 (±0.8) h, range 3.0–12.9 h; norfluoxetine AUC 11.44 (±0.74), Cmax 138.3 (±9.6) ng/mL, Tmax 12.8 (±1.7) h, T½ 49 (±3) h, range 33.0–64.0 h. Accumulation: "although steady state appeared to be reached within 10 days in the 21-day study, a continuous increase in trough concentrations was observed in a one year, multiple-dose laboratory safety study. In this study, dogs administered a 1 mg/kg dose of fluoxetine had plasma fluoxetine concentrations that continued to increase over the one-year dosing period. A similar increase in concentrations was observed with norfluoxetine." Washout: "because fluoxetine and its major metabolite, norfluoxetine, have long half-lives, a 6-week washout interval should be observed following discontinuation of therapy with RECONCILE chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine." Effectiveness: "at the end of the study, 73% of dogs treated with RECONCILE chewable tablets showed significant improvement (p=0.010) as compared to 51% of dogs treated with behavior modification alone"; "during the course of therapy, 42% of dogs showed improvement within the first week, which was significantly greater (p=0.005) than with behavior modification alone (18%)"; the study randomized "117 dogs… to 1-2 mg/kg/day of RECONCILE chewable tablets and 112 dogs… to the control group" across "34 investigative sites in the United States and Canada" for 229 dogs total. Client leaflet: "some dogs may show improvement within 1-2 weeks of starting treatment with RECONCILE chewable tablets. Others may take as long as 8 weeks to show improvement." Weight loss (Table 2 and text): "a 5% or greater weight loss (when compared to initial, pre-study body weight) was observed in 58 (29.6%) of dogs treated with RECONCILE chewable tablets and 24 (13.0%) of dogs in the control group." Contraindications: "RECONCILE chewable tablets are contraindicated for use in dogs with epilepsy or a history of seizures"; "should not be given concomitantly with drugs that lower the seizure threshold (e.g., phenothiazines such as acepromazine or chlorpromazine)"; "should not be given in combination with a monoamine oxidase inhibitor (MAOI)… or within a minimum of 14 days of discontinuing therapy with an MAOI." Precautions and adverse reactions: "seizures may occur in dogs treated with RECONCILE chewable tablets, even in dogs without a history of epilepsy or seizures"; client leaflet: "the most serious side effect is seizures (convulsions), which in rare and severe cases can result in death"; "RECONCILE chewable tablets are not recommended for the treatment of aggression"; the product is "for use in dogs and puppies 6 months of age or older, and 8.8 pounds (4.0 kilograms) or greater." How supplied: "8mg, 16mg, 32mg and 64mg strengths; as 30 or 90 tablets per bottle." dailymed.nlm.nih.gov Retrieved 2026-09-08.
- VCA Animal Hospitals. Fluoxetine — described as "an SSRI (selective serotonin reuptake inhibitor) antidepressant used to treat a variety of behavioral disorders in dogs and cats. The FDA approved form for dogs is labeled to treat separation anxiety." Onset: "this medication can take up to a few weeks before full effects are noted." Missed dose: "if you miss a dose, give it as soon as you remember, and then continue with the regular dosing schedule. However, if it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not give the pet two doses at once." Discontinuation: "do not stop this medication abruptly unless instructed by your veterinarian." vcahospitals.com Retrieved 2026-09-08.
- Odore R, Rendini D, Badino P, et al. Behavioral Therapy and Fluoxetine Treatment in Aggressive Dogs: A Case Study. Animals (Basel), 2020;10(5):832. Eight dogs diagnosed with owner-directed dominance aggression received fluoxetine at 1.5 mg/kg/day with a behavior modification program, assessed before treatment and after one, two, four and six months. "Increasing concentrations of circulating fluoxetine and norfluoxetine were measured throughout the follow-up. Correlation between norfluoxetine levels and clinical scores was observed at T4." Conclusion: "in dogs norfluoxetine levels seem reliable in predicting clinical efficacy." PMC7278467 (open access) Retrieved 2026-09-08.
- Merck Veterinary Manual. Common Drugs Used to Treat Behavior Problems in Dogs — fluoxetine, an SSRI, dosed at "1–2 mg/kg, PO, q 24 h"; FDA-approved for canine separation anxiety with off-label use in anxiety disorders, phobias, conflict and fear aggression, compulsive disorders, excessive arousal, impulsivity and urine marking. Adverse effects: "anorexia, hyporexia, lethargy, sedation, vomiting, diarrhea, restlessness, vocalization, agitation, tremors, seizures, changes in urine frequency. Aggression has also been reported." merckvetmanual.com Retrieved 2026-09-08.
- Fitzgerald KT, Bronstein AC. Selective serotonin reuptake inhibitor exposure. Topics in Companion Animal Medicine, 2013;28(1):13–17. "Clinical signs of SSRI overdose result from excessive amounts of serotonin in the central nervous system. These signs include nausea, vomiting, mydriasis, hypersalivation, and hyperthermia. Clinical signs are dose dependent and higher dosages may result in the serotonin syndrome that manifests itself as ataxia, tremors, muscle rigidity, hyperthermia, diarrhea, and seizures." "The relative safety of the SSRIs in overdose despite the occurrence of serotonin syndrome makes them more desirable than other antidepressants. The prognosis in animals that receive treatment is excellent. In one retrospective study, there were no deaths in 313 SSRI-poisoned dogs." PubMed 23796482 Retrieved 2026-09-08.
- ASPCA Animal Poison Control Center. Animal Poison Control — the centre's number is given as "(888) 426-4435"; "we are available 24/7, 365 days a year, so you can get expert guidance the moment a poisoning concern arises"; "a consultation fee may apply." aspca.org Retrieved 2026-09-08.
- Weng HY, Morrison JA, Topdjian K, Ogata N. Real-world data on behavioral practices for dogs in primary care veterinary hospitals in the United States (2010-2020). Journal of the American Veterinary Medical Association, 2025;263(7):1–7. "A total of 32,468,046 canine medical records were retrieved. The overall prescription percentage was 0.03% for clomipramine, 0.02% for fluoxetine, and 1.33% for trazodone during the study period." "The frequency of behavior problem labels increased 10-fold from 1.0% in 2010 to 10.2% in 2020, with an overall frequency of 5%." "Notably, about 70% of dogs receiving psychoactive drugs had no associated behavior problem labels used in the study." PubMed 40107234 Retrieved 2026-09-08.
- Karagiannis CI, Burman OH, Mills DS. Dogs with separation-related problems show a "less pessimistic" cognitive bias during treatment with fluoxetine (Reconcile™) and a behaviour modification plan. BMC Veterinary Research, 2015;11:80. Five dogs showing separation-related problems were treated with fluoxetine chewable tablets and a standard behaviour modification plan for two months, with seven unaffected dogs as controls. "On weeks 2 and 6 of treatment, SRP dogs displayed similar responses in the cognitive bias test to control dogs, consistent with the possible normalization of affect during treatment, with this effect more pronounced at week 6." PMC4393593 (open access) Retrieved 2026-09-08.